DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study
- DOI
- 10.1097/dss.0000000000002531
- Published
- 2020-08-06
- Container
- Dermatologic Surgery
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1097/dss.0000000000002531,
title = {DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study},
author = {Sabrina G. Fabi and Joel L. Cohen and Lawrence J. Green and Sunil Dhawan and Theda C. Kontis and Leslie Baumann and Todd M. Gross and Conor J. Gallagher and Jessica Brown and Roman G. Rubio},
year = {2020},
journal = {Dermatologic Surgery},
doi = {10.1097/dss.0000000000002531},
url = {https://doi.org/10.1097/dss.0000000000002531}
}RIS
TY - JOUR TI - DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study AU - Sabrina G. Fabi AU - Joel L. Cohen AU - Lawrence J. Green AU - Sunil Dhawan AU - Theda C. Kontis AU - Leslie Baumann AU - Todd M. Gross AU - Conor J. Gallagher AU - Jessica Brown AU - Roman G. Rubio PY - 2020 JO - Dermatologic Surgery DO - 10.1097/dss.0000000000002531 UR - https://doi.org/10.1097/dss.0000000000002531 ER -
APA
Fabi, S. G., Cohen, J. L., Green, L. J., Dhawan, S., Kontis, T. C., Baumann, L., Gross, T. M., Gallagher, C. J., Brown, J., & Rubio, R. G. (2020). DaxibotulinumtoxinA for Injection for the Treatment of Glabellar Lines: Efficacy Results From SAKURA 3, a Large, Open-Label, Phase 3 Safety Study. Dermatologic Surgery. https://doi.org/10.1097/dss.0000000000002531
Source records
- crossref · retrieved 2026-09-27T01:38:21.882Z